Assessment of In-Vitro Antioxidant Potential of Ethyl Acetate Fraction of Hydroalcoholic Extract of Aerva Javanica Linn. Flowering Tops
DOI:
https://doi.org/10.22270/ajprd.v7i5.520Keywords:
Aerva, SOD, superoxide, antioxidant, ascorbic acid, FRAPAbstract
Aerva javanica (Amaranthaceae) is a grey coloured woolly perennial tomentose shrub. Its traditional and folklore usage motivates further investigation on its pharmacognostic parameters and pharmacological potential. Therefore, in order to establish its antioxidant potential, DPPH, SOD and superoxide scavenging and total antioxidant capacity, were determined. Hydro-alcoholic extract (CE) was prepared from flowering tops of A. javanica. In order to work further on activity guided fractions, ethyl acetate (AJEAF) fraction was prepared. For in-vitro evaluation, ascorbic acid was used as standard antioxidant compound. In DPPH assay IC50 was determined as 89.00 µg/ml, as compared with standard ascorbic acid with IC50 21.80 µg/ml, with a concentration dependent scavenging of free radical. Superoxide scavenging potential in terms of SOD expressed as IC50, was determined as 61.904 µg /ml for AJEAF in contrast to 132.413 µg /ml for standard ascorbic acid. This was equivalent to 16.154 Eq SOD units /mg (EAF) per mg of sample respectively against 7.552 Eq SOD units /mg of standard. Total antioxidant capacity was found to be 283.67 mg Ascorbic acid Eq /g. Results indicated that fraction (AJEAF had significant antioxidant potential which expressed the prospective potential of fraction against metabolic disorders.
Downloads
References
2. Laxane SN, Swarnkar SK, Zanwar SB, Manjunath Setty M. Antiinflammatory studies of the alcoholic extract of Zornia gibbosa. Pharmacologyonline. 2011; 1:67–76
3. Setty M, Swarnkar S, Laxane N, Laxane S. Design, Development and Evaluation of Herbal Transdermal Patches for Anti- Inflammatory Activity. Int J Pharm. 2018; 8(3):33–50.
4. Wahid A, Sridhar BK, Shivakumar S. Preparation and evaluation of transdermal drug delivery system of etoricoxib using modified chitosan. Indian J Pharm Sci. 2008 ;70(4):455–60.
5. Arora P, Mukherjee B. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J Pharm Sci. 2002 ; 91(9):2076–89.
6. Draize J, Woodard G, Calvery H. Methods for the Study of Irritation and Toxicity of Substances Applied Topically to the Skin and Mucous Membranes. J Pharmacol Exp Ther. 1944;82(3).
7. Khunteta A, Gupta MK, Swarnkar SK. Formulation of Rapid Dissolving Films Containing Granisetron Hydrochloride and Ondansetron Hydrochloride. J Drug Deliv Ther. 2019; 9(4-A):516–27.
8. Sood A, Ashokraj Y, Panchagnula R. Use of Extrusion–Spheronization to Develop Controlled-Release Dosage Forms for Diltiazem Hydrochloride. Pharm Technol. 2004 ;4:62.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).